Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Finasteride causes lasting fertility decrease in rats.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Nutrients like vitamins, copper, zinc, and amino acids are crucial for healthy hair and wool growth.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Hair loss drugs may cause sexual issues and infertility in men.

Vitamin D receptor helps control hair growth genes in skin cells.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Some skin diseases and their treatments can negatively affect male fertility.